M
Mohammad Reza Karimzadeh
Publications - 17
Citations - 446
Mohammad Reza Karimzadeh is an academic researcher. The author has contributed to research in topics: Cancer & microRNA. The author has an hindex of 8, co-authored 17 publications receiving 237 citations.
Papers
More filters
Journal ArticleDOI
Kaempferol and docetaxel diminish side population and down-regulate some cancer stem cell markers in breast cancer cell line MCF-7
Journal ArticleDOI
Modulation of the Expression of Long Non-Coding RNAs H19, GAS5, and MIAT by Endurance Exercise in the Hearts of Rats with Myocardial Infarction
Saeideh Jafarinejad Farsangi,Farzaneh Rostamzadeh,Mozhgan Sheikholeslami,Elham Jafari,Mohammad Reza Karimzadeh +4 more
TL;DR: The beneficial effect of Ex on the improvement of cardiac function and reduction of fibrosis in infarcted heart possibly through regulation of the expression of lncRNAs: H19, GAS5, and MIAT.
Journal ArticleDOI
Exosomal Long Noncoding RNAs: Insights into Emerging Diagnostic and Therapeutic Applications in Lung Cancer.
Mohammad Reza Karimzadeh,Mohammad Reza Seyedtaghia,Mohammad Soudyab,Maria Nezamnia,Jason Kidde,Amirhossein Sahebkar +5 more
TL;DR: The advantages of exosomal lncRNAs as biomarkers and therapeutic targets will be discussed in addition to reviewing studies of their application in lung cancer.
Journal ArticleDOI
microRNAs: key modulators of disease-modifying therapies in multiple sclerosis.
Naeim Ehtesham,Meysam Mosallaei,Mohammad Reza Karimzadeh,Hossein Moradikazerouni,Mohammadreza Sharifi +4 more
TL;DR: The modulation of miRNAs by DMTs in cells and pathways involved in MS is discussed, highlighting their role in pathogenetic of MS.
Journal ArticleDOI
Alterations of epigenetic landscape in Down syndrome carrying pregnancies: A systematic review of case-control studies.
Mohammad Reza Karimzadeh,Naeim Ehtesham,Deniz Mortazavi,Sara Azhdari,Meysam Mosallaei,Maria Nezamnia +5 more
TL;DR: In this article, a systematic review of case-control publications that have examined the differences in epigenetic landscape between pregnancies bearing euploid fetuses and those affected with Down syndrome was performed to provide a focused insight into the pathophysiology of DS and also novel biomarkers for NIPD of DS.